Search for other papers by Laura Fugazzola in
Google Scholar
PubMed
Calcitonin, the Marker of Medullary Thyroid Cancer Medullary thyroid cancer (MTC) can be a very aggressive tumor. Significant differences in survival have been reported according to the stage of the tumor at the time of diagnosis, the survival
Search for other papers by Fabio Maino in
Google Scholar
PubMed
Search for other papers by Cristina Dalmiglio in
Google Scholar
PubMed
Search for other papers by Nicoletta Benenati in
Google Scholar
PubMed
Search for other papers by Michele Campanile in
Google Scholar
PubMed
Search for other papers by Tania Pilli in
Google Scholar
PubMed
Search for other papers by Raffaella Forleo in
Google Scholar
PubMed
Search for other papers by Lucia Brilli in
Google Scholar
PubMed
Search for other papers by Cristina Ciuoli in
Google Scholar
PubMed
Search for other papers by Silvia Cantara in
Google Scholar
PubMed
Search for other papers by Marco Capezzone in
Google Scholar
PubMed
Search for other papers by Alessandra Cartocci in
Google Scholar
PubMed
Search for other papers by Furio Pacini in
Google Scholar
PubMed
Search for other papers by Maria Grazia Castagna in
Google Scholar
PubMed
Introduction Calcitonin (CT), a 32-amino acid calcium-lowering peptide secreted by the C-cells (parafollicular cells) of the thyroid, is used as a marker for the diagnosis and the follow-up of medullary thyroid cancer (MTC) [ 1 ]. In patients
Institute of Clinical Medicine, University of Oslo, Oslo, Norway
Search for other papers by Else Marie Opsahl in
Google Scholar
PubMed
Department of Pathology, Haukeland University Hospital Bergen, Bergen, Norway
Search for other papers by Lars Andreas Akslen in
Google Scholar
PubMed
Search for other papers by Ellen Schlichting in
Google Scholar
PubMed
Search for other papers by Turid Aas in
Google Scholar
PubMed
Search for other papers by Katrin Brauckhoff in
Google Scholar
PubMed
Search for other papers by Anne Irene Hagen in
Google Scholar
PubMed
Search for other papers by Alf Frimann Rosenlund in
Google Scholar
PubMed
Search for other papers by Eva Sigstad in
Google Scholar
PubMed
Search for other papers by Krystyna K. Grøholt in
Google Scholar
PubMed
Search for other papers by Lars H. Jørgensen in
Google Scholar
PubMed
Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway
Search for other papers by Trine Bjøro in
Google Scholar
PubMed
disease in the lateral neck [ 3 , 14 ]. High-resolution ultrasound is important in disease staging, enabling the detection of even very small metastatic lymph nodes but not micrometastases. Calcitonin is a good tumor marker in MTC. As a rule, it is
Search for other papers by Cléber P. Camacho in
Google Scholar
PubMed
Search for other papers by Susan C. Lindsey in
Google Scholar
PubMed
Search for other papers by Teresa S. Kasamatsu in
Google Scholar
PubMed
Fleury Medicine and Health, São Paulo, Brazil
Search for other papers by Alberto L. Machado in
Google Scholar
PubMed
Search for other papers by João Roberto M. Martins in
Google Scholar
PubMed
Fleury Medicine and Health, São Paulo, Brazil
Search for other papers by Rosa Paula M. Biscolla in
Google Scholar
PubMed
Search for other papers by Magnus R. Dias da Silva in
Google Scholar
PubMed
Fleury Medicine and Health, São Paulo, Brazil
Search for other papers by José Gilberto H. Vieira in
Google Scholar
PubMed
Fleury Medicine and Health, São Paulo, Brazil
Search for other papers by Rui M.B. Maciel in
Google Scholar
PubMed
Introduction Serum calcitonin (sCT) is a useful biomarker for medullary thyroid cancer (MTC) and is employed for its diagnosis and follow-up monitoring [ 1 ]. In addition, some guidelines advocate sCT measurements for the differential
Endocrinology Service, Department of Medicine, Hospital Universitário Clementino Fraga Filho, Rio de Janeiro, Brazil
Search for other papers by Renata Alencar in
Google Scholar
PubMed
Search for other papers by Daniel Barretto Kendler in
Google Scholar
PubMed
Search for other papers by Fernanda Andrade in
Google Scholar
PubMed
Search for other papers by Carla Nava in
Google Scholar
PubMed
Search for other papers by Daniel Bulzico in
Google Scholar
PubMed
Search for other papers by Cencita Cordeiro de Noronha Pessoa in
Google Scholar
PubMed
Endocrinology Service, Department of Medicine, Hospital Universitário Clementino Fraga Filho, Rio de Janeiro, Brazil
Search for other papers by Rossana Corbo in
Google Scholar
PubMed
Endocrinology Service, Department of Medicine, Hospital Universitário Clementino Fraga Filho, Rio de Janeiro, Brazil
Search for other papers by Fernanda Vaisman in
Google Scholar
PubMed
monitored after for serum levels of calcitonin and carcinoembryonic antigen (CEA) usually twice or three times a year. After 2015, CA19-9 serum levels were also routinely measured in these patients and were collected usually at each semester. Imaging tests
Search for other papers by Isabelle Clinckspoor in
Google Scholar
PubMed
Search for other papers by Anne-Catherine Gérard in
Google Scholar
PubMed
Search for other papers by Jacqueline Van Sande in
Google Scholar
PubMed
Search for other papers by Marie-Christine Many in
Google Scholar
PubMed
Search for other papers by Lieve Verlinden in
Google Scholar
PubMed
Search for other papers by Roger Bouillon in
Google Scholar
PubMed
Search for other papers by Geert Carmeliet in
Google Scholar
PubMed
Department of Endocrinology, University Hospitals Leuven, Leuven, Belgium
Search for other papers by Chantal Mathieu in
Google Scholar
PubMed
Search for other papers by Annemieke Verstuyf in
Google Scholar
PubMed
Department of Endocrinology, University Hospitals Leuven, Leuven, Belgium
Search for other papers by Brigitte Decallonne in
Google Scholar
PubMed
antithyroid antibodies and abnormal thyroid function in humans [ 19 , 20 ], and to modulate autoimmune hyperthyroidism in mice [ 21 ]. Apart from inhibiting osteoclast-mediated bone resorption and increasing renal calcium and phosphate excretion, calcitonin
Search for other papers by Simona Censi in
Google Scholar
PubMed
Search for other papers by Elisabetta Cavedon in
Google Scholar
PubMed
Search for other papers by Sara Watutantrige-Fernando in
Google Scholar
PubMed
Search for other papers by Susi Barollo in
Google Scholar
PubMed
Search for other papers by Loris Bertazza in
Google Scholar
PubMed
Search for other papers by Jacopo Manso in
Google Scholar
PubMed
Search for other papers by Maurizio Iacobone in
Google Scholar
PubMed
Search for other papers by Davide Nacamulli in
Google Scholar
PubMed
Search for other papers by Francesca Galuppini in
Google Scholar
PubMed
Search for other papers by Gianmaria Pennelli in
Google Scholar
PubMed
Search for other papers by Caterina Mian in
Google Scholar
PubMed
What Is Known about This Topic? The most important clinical prognostic factors for medullary thyroid carcinoma are basal serum calcitonin (Ctn) at diagnosis and pathological stage. When the diameter of the primary cancer exceeds 2
Search for other papers by R. Elisei in
Google Scholar
PubMed
Search for other papers by M. Alevizaki in
Google Scholar
PubMed
Search for other papers by B. Conte-Devolx in
Google Scholar
PubMed
Search for other papers by K. Frank-Raue in
Google Scholar
PubMed
Search for other papers by V. Leite in
Google Scholar
PubMed
Search for other papers by G.R. Williams in
Google Scholar
PubMed
were identified by searching PubMed MEDLINE at PubMed (NLM) using the following search terms: medullary thyroid cancer, RET oncogene, calcitonin, calcium, RET gene carriers, MEN 2, pheochromocytoma, hyperparathyroidism, RET genetic counseling, and
Search for other papers by Catarina Silvestre in
Google Scholar
PubMed
Search for other papers by Joaquim Sampaio Matias in
Google Scholar
PubMed
Search for other papers by Helena Proença in
Google Scholar
PubMed
Search for other papers by Maria João Bugalho in
Google Scholar
PubMed
Introduction Calcitonin (Ctn) is a 32-amino acid polypeptide secreted by the parafollicular cells of the thyroid, called “C” cells. With a known important role in regulating blood calcium in fish and rodents, the role of Ctn in human calcium
Search for other papers by Abbas Al-Kurd in
Google Scholar
PubMed
Search for other papers by David J. Gross in
Google Scholar
PubMed
Search for other papers by David Zangen in
Google Scholar
PubMed
Search for other papers by Karine Atlan in
Google Scholar
PubMed
Search for other papers by Haggi Mazeh in
Google Scholar
PubMed
Search for other papers by Simona Grozinsky-Glasberg in
Google Scholar
PubMed
should be revised to recommend calcitonin screening and prophylactic thyroidectomy at an earlier age in such patients. Due to the rarity of these patients, cumulative literature on the topic is essential, and, therefore, reports such as the present one